Occurrence of mosaic trisomy 22 and pericentric inversion of chromosome 9 in a patient with a good prognosis.
Chromosome 22 trisomy
Chromosome abnormalities
Genetic diagnosis
Mosaicism
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
13 11 2023
13 11 2023
Historique:
received:
16
02
2023
accepted:
19
10
2023
medline:
15
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
epublish
Résumé
Complete trisomy 22 is a rare chromosomal condition that is incompatible with life. However, mosaic trisomy 22 usually has prolonged survival compatibility and may present a good prognosis depending on the tissues affected. Herein, we described a male patient with the occurrence of mosaic trisomy 22 associated with the inversion of chromosome 9, with karyotype 47, XY, inv (9) (p11q13), + 22 [5] / 46, XY, inv(9) (p11q13) [45] and arr 22q11.1 ~ q13.33(16,417008-51,219,009)x2 ~ 3. It is not possible to infer, in general, the clinical characteristics associated with mosaic trisomy 22. However, the patient presented common clinical features observed in reported cases (in parentheses the percentage observed comparing all reported cases): facial dysmorphia (100%), delay in motor development/growth (82%), cardiac abnormalities (73%), ear abnormalities (55%) and facial and/or body asymmetry (55%), in addition to hypotonia, skin spots, hypoplastic nails. Given the survival and quality of life associated with multidisciplinary treatment, it can be concluded that the patient has a good prognosis. Conclusively, we're presenting the occurrence of mosaic trisomy 22 and chromosome 9 inversion in the patient with favorable prognosis. Thus, this study proposed a guide which should be inserted in databases of rare genetic conditions to help genetic counselors define mosaic trisomy 22 diagnosis.
Identifiants
pubmed: 37957608
doi: 10.1186/s12920-023-01709-2
pii: 10.1186/s12920-023-01709-2
pmc: PMC10644605
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
286Informations de copyright
© 2023. The Author(s).
Références
Am J Med Genet A. 2011 Feb;155A(2):434-8
pubmed: 21271668
Reprod Med Biol. 2019 Jun 24;18(3):296-301
pubmed: 31312110
Medicina (Kaunas). 2022 Jan 05;58(1):
pubmed: 35056387
Exp Ther Med. 2018 Oct;16(4):3589-3595
pubmed: 30233713
Maedica (Bucur). 2012 Jan;7(1):25-9
pubmed: 23118816
Cytogenet Genome Res. 2017;152(2):81-89
pubmed: 28662500
Ann Genet. 2001 Oct-Dec;44(4):183-6
pubmed: 11755102
J Obstet Gynaecol Res. 2010 Oct;36(5):1116-20
pubmed: 20722987
Reprod Biomed Online. 2017 Jul;35(1):72-80
pubmed: 28479119
Curr Mol Med. 2022;22(5):385-400
pubmed: 34365947
J Hum Genet. 2001;46(5):245-50
pubmed: 11355013
Yonsei Med J. 2010 Sep;51(5):775-80
pubmed: 20635455
J Int Med Res. 2020 Sep;48(9):300060520957820
pubmed: 32957812
Am J Med Genet. 1995 Dec 4;59(4):411-3
pubmed: 8585556
Mol Syndromol. 2013 Jan;3(6):262-9
pubmed: 23599696
Cytogenet Genome Res. 2019;158(4):171-183
pubmed: 31434098
Am J Med Genet Suppl. 1990;7:162-8
pubmed: 1981475
Hum Genet. 1981;56(3):249-62
pubmed: 7239508
J Clin Lab Anal. 2019 Feb;33(2):e22663
pubmed: 30259573
Cytogenet Genome Res. 2021;161(5):225-226
pubmed: 34407535
Andrologia. 2006 Aug;38(4):122-7
pubmed: 16872463
Genes (Basel). 2021 Aug 24;12(9):
pubmed: 34573276
Ophthalmic Genet. 2004 Mar;25(1):53-6
pubmed: 15255116
Genet Med. 2005 Apr;7(4):251-63
pubmed: 15834243
Am J Med Genet A. 2013 May;161A(5):1126-31
pubmed: 23529842
Am J Med Genet A. 2014 Dec;164A(12):3187-93
pubmed: 25257307
Am J Med Genet A. 2007 Nov 15;143A(22):2744-6
pubmed: 17937440
Clin Pediatr (Phila). 1988 Sep;27(9):451-4
pubmed: 3046809
Annu Rev Genet. 2020 Nov 23;54:487-510
pubmed: 32916079
Am J Med Genet A. 2005 Jan 15;132A(2):223-5
pubmed: 15551336
Am J Med Genet. 1997 Sep 5;71(4):406-13
pubmed: 9286446
Obstet Gynecol Sci. 2014 Nov;57(6):518-25
pubmed: 25469342
Taiwan J Obstet Gynecol. 2019 Sep;58(5):692-697
pubmed: 31542095
J Assist Reprod Genet. 2020 Jul;37(7):1703-1710
pubmed: 32451813